Financials

Discussions Technicals Seasonals

348150 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

KoBioLabs, Inc. engages in the research and development of the microbiome. Its product is involved in the industries such as therapeutics, diagnostics, cosmetics, agriculture, and veterinary medicine. The company was founded by Ko Gwang-Pyo on August 11, 2014 and is headquartered in Seoul, South Korea.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

348150 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company